[Federal Register Volume 62, Number 89 (Thursday, May 8, 1997)]
[Notices]
[Page 25211]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-11927]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on March 17, 1997, Roche 
Diagnostic Systems, Inc., 1080 U.S. Highway 202, Somerville, New Jersey 
08876-3771, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as a bulk manufacturer of the 
basic classes of controlled substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
Lysergic acid diethylamide (7315)...........  I                         
Tetrahydrocannabinols (7370)................  I                         
Phencyclidine (7471)........................  II                        
Methadone (9250)............................  II                        
Morphine (9300).............................  II                        
------------------------------------------------------------------------

    The firm plans to manufacture small quantities of the listed 
controlled substances for incorporation in drug of abuse detection 
kits.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Acting Deputy Assistant Administrator, Office of Diversion 
Control, Drug Enforcement Administration, United States Department of 
Justice, Washington, DC 20537, Attention: DEA Federal Register 
Representative (CCR), and must be filed no later than July 7, 1997.

    Dated: March 31, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration.
[FR Doc. 97-11927 Filed 5-7-97; 8:45 am]
BILLING CODE 4410-09-M